E-ISSN 2231-3206 | ISSN 2320-4672
 

Original Research

Online Publishing Date:
11 / 03 / 2020

 


A study on antimicrobial use in the management of duodenal perforation and its cost-effective analysis

Ellabathini Hima Bindu, Merughu Padma Latha, Mohathasim Billah A, Rizwan Uz Zaman.


Abstract
Background: Duodenal perforation is mostly seen in gastrointestinal perforation due to either disease or trauma, which forms nearly one-third of acute abdominal catastrophe. Although modern sophisticated gadgets are available in the diagnostic armamentarium, proper history elicitation, methodological physical examination, and sharp clinical observation play a major role in accurate diagnosis of acute abdominal conditions. In duodenal perforation, there is a sudden release of gastric contents into peritoneal cavity, which leads to a devastating sequence of events such as chemical and bacterial peritonitis, fluid and electrolyte imbalance, toxemia, septicemia, circulatory failure, and finally death.

Aims and Objectives: The aim of this study was to evaluate the use of antibiotics in the management of duodenal perforation. This was a non-invasive prospective observational study. Seventy-nine patients with duodenal perforation undergoing elective and emergency surgery from the surgery wards were selected for the study on satisfying the inclusion criteria.

Materials and Methods: The study method involves the selection of patients based on the inclusion and exclusion criteria, to record the prescribing pattern of antibiotics in the post-operative wards of surgery, to find the effectiveness of the antibiotics prescribed in relation to the number of hospital days, and to analyze the cost-effectiveness using statistical tool. This study was conducted from May 2018 to October 2018.

Results: Data were collected from 79 patients. It was observed that the incidence of perforation was higher in males than females (7:1) in the age group of 31–40 years (28%) and mean Li-standard deviation is 11.28 ± 7.63. Pip/taz was most commonly prescribed (29 out of 79 cases). In terms of cost, on an average, pip/taz was found to involve highest amount. When the mean deviation of hospital stay was taken into account, piperacillin was at lower margin when compared with others (10.23 ± 2.59). The statistical analysis of hospital stay shows a significant difference between all three drugs Cefotaxime, ceftriaxone and cefixime (P ≤ 0.017, P ≤ 0.0139, and P ≤ 0.085, respectively). Thus, 26 patients out of 29 patients were successfully cured with pip/taz with a mean hospital stay of (10,23±2,59) days and three patients were discharged against medical advice. We considered cost effective involved in the treatment with drugs as health-care cost in rupees and number of days taken to cure as clinical outcome. From this, we calculated average cost-effective ratio and the highest being pip/taz (109.29) when compared to cefotaxime (97.1).

Conclusions: From our study, we conclude that piperacillin/tazobactam should be the choice of antimicrobials for this duodenal perforation.

Key words: Duodenal Perforation; Antimicrobial; Cost-Effective Analysis; Piperacillin/Tazobactam


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Ellabathini Hima Bindu
Articles by Merughu Padma Latha
Articles by Mohathasim Billah A
Articles by Rizwan Uz Zaman
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Bindu EH, Latha MP, A MB, Zaman RU. A study on antimicrobial use in the management of duodenal perforation and its cost-effective analysis. Natl J Physiol Pharm Pharmacol. 2020; 10(5): 355-358. doi:10.5455/njppp.2020.10.12387201902032020


Web Style

Bindu EH, Latha MP, A MB, Zaman RU. A study on antimicrobial use in the management of duodenal perforation and its cost-effective analysis. https://www.njppp.com/?mno=78265 [Access: March 14, 2024]. doi:10.5455/njppp.2020.10.12387201902032020


AMA (American Medical Association) Style

Bindu EH, Latha MP, A MB, Zaman RU. A study on antimicrobial use in the management of duodenal perforation and its cost-effective analysis. Natl J Physiol Pharm Pharmacol. 2020; 10(5): 355-358. doi:10.5455/njppp.2020.10.12387201902032020



Vancouver/ICMJE Style

Bindu EH, Latha MP, A MB, Zaman RU. A study on antimicrobial use in the management of duodenal perforation and its cost-effective analysis. Natl J Physiol Pharm Pharmacol. (2020), [cited March 14, 2024]; 10(5): 355-358. doi:10.5455/njppp.2020.10.12387201902032020



Harvard Style

Bindu, E. H., Latha, . M. P., A, . M. B. & Zaman, . R. U. (2020) A study on antimicrobial use in the management of duodenal perforation and its cost-effective analysis. Natl J Physiol Pharm Pharmacol, 10 (5), 355-358. doi:10.5455/njppp.2020.10.12387201902032020



Turabian Style

Bindu, Ellabathini Hima, Merughu Padma Latha, Mohathasim Billah A, and Rizwan Uz Zaman. 2020. A study on antimicrobial use in the management of duodenal perforation and its cost-effective analysis. National Journal of Physiology, Pharmacy and Pharmacology, 10 (5), 355-358. doi:10.5455/njppp.2020.10.12387201902032020



Chicago Style

Bindu, Ellabathini Hima, Merughu Padma Latha, Mohathasim Billah A, and Rizwan Uz Zaman. "A study on antimicrobial use in the management of duodenal perforation and its cost-effective analysis." National Journal of Physiology, Pharmacy and Pharmacology 10 (2020), 355-358. doi:10.5455/njppp.2020.10.12387201902032020



MLA (The Modern Language Association) Style

Bindu, Ellabathini Hima, Merughu Padma Latha, Mohathasim Billah A, and Rizwan Uz Zaman. "A study on antimicrobial use in the management of duodenal perforation and its cost-effective analysis." National Journal of Physiology, Pharmacy and Pharmacology 10.5 (2020), 355-358. Print. doi:10.5455/njppp.2020.10.12387201902032020



APA (American Psychological Association) Style

Bindu, E. H., Latha, . M. P., A, . M. B. & Zaman, . R. U. (2020) A study on antimicrobial use in the management of duodenal perforation and its cost-effective analysis. National Journal of Physiology, Pharmacy and Pharmacology, 10 (5), 355-358. doi:10.5455/njppp.2020.10.12387201902032020